Status:
COMPLETED
An Interaction Study With Digoxin and AZD1305
Lead Sponsor:
AstraZeneca
Conditions:
Atrial Fibrillation
Eligibility:
MALE
20-45 years
Phase:
PHASE1
Brief Summary
The primary purpose of this study is to learn more about how digoxin is handled by the body, i.e. absorption, distribution, metabolism and excretion, when administered alone and in combination with AZ...
Eligibility Criteria
Inclusion
- A body mass index (BMI=weight/height2) of 19 to 30 kg/m2
Exclusion
- Potassium outside normal reference values
- ECG findings outside normal range
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00712465
Start Date
August 1 2008
End Date
November 1 2008
Last Update
December 3 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Gothenburg, Sweden